Interleukin-11-expressing fibroblasts have a unique gene signature correlated with poor prognosis of colorectal cancer.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 33863879.
- Also identified by DOI 10.1038/s41467-021-22450-3 and PMC identifier 8052408.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Interleukin (IL)-11 is a member of the IL-6 family of cytokines and is involved in multiple cellular responses, including tumor development. However, the origin and functions of IL-11-producing (IL-11<sup>+</sup>) cells are not fully understood. To characterize IL-11<sup>+</sup> cells in vivo, we generate Il11 reporter mice. IL-11<sup>+</sup> cells appear in the colon in murine tumor and acute colitis models. Il11ra1 or Il11 deletion attenuates the development of colitis-associated colorectal cancer. IL-11<sup>+</sup> cells express fibroblast markers and genes associated with cell proliferation and tissue repair. IL-11 induces the activation of colonic fibroblasts and epithelial cells through phosphorylation of STAT3. Human cancer database analysis reveals that the expression of genes enriched in IL-11<sup>+</sup> fibroblasts is elevated in human colorectal cancer and correlated with reduced recurrence-free survival. IL-11<sup>+</sup> fibroblasts activate both tumor cells and fibroblasts via secretion of IL-11, thereby constituting a feed-forward loop between tumor cells and fibroblasts in the tumor microenvironment.
Medical subject headings
- Adenoma
- Colitis
- Colorectal Neoplasms
- Fibroblasts
- Interleukin-11
- Neoplasm Recurrence, Local